Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars.

Moura CS, Etingin A, Lukusa L, Singh H, Narula N, Targownik LE, Leung Y, Zezos P, Polewiczowska-Nowak B, Afif W, Bernatsky S

Open source

DOI: 10.3748/wjg.v32.i9.114580
Published: 2026 Mar 7
Container: World journal of gastroenterology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3748/wjg.v32.i9.114580,
  title = {Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars.},
  author = {Moura CS and Etingin A and Lukusa L and Singh H and Narula N and Targownik LE and Leung Y and Zezos P and Polewiczowska-Nowak B and Afif W and Bernatsky S},
  year = {2026},
  journal = {World journal of gastroenterology},
  doi = {10.3748/wjg.v32.i9.114580},
  url = {https://doi.org/10.3748/wjg.v32.i9.114580}
}

RIS

TY  - JOUR
TI  - Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars.
AU  - Moura CS
AU  - Etingin A
AU  - Lukusa L
AU  - Singh H
AU  - Narula N
AU  - Targownik LE
AU  - Leung Y
AU  - Zezos P
AU  - Polewiczowska-Nowak B
AU  - Afif W
AU  - Bernatsky S
PY  - 2026
JO  - World journal of gastroenterology
DO  - 10.3748/wjg.v32.i9.114580
UR  - https://doi.org/10.3748/wjg.v32.i9.114580
ER  -

APA

CS, M., A, E., L, L., H, S., N, N., LE, T., Y, L., P, Z., B, P., W, A., & S, B. (2026). Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars.. World journal of gastroenterology. https://doi.org/10.3748/wjg.v32.i9.114580

Source records

pubmed · retrieved 2026-09-27T12:08:03.493Z
europe-pmc · retrieved 2026-09-27T12:08:03.508Z